Skip to main content
UniHealth

Doctor search

Ashley Ann Jezierski, PA-C

Physician Assistant · Stanford

NPI 1336524099

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Ashley Ann Jezierski’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence C53399 · Current

Licensed to practise in California · since 2008 · expires 2028-04-30 · Medical College of Wisconsin.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Drugs they prescribed that Part D paid

$3,234

Pharmacies billed $3,234 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

83 generic and fewer than 11 brand-name prescriptions · $3,234 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Clopidogrel12$101$8
Atorvastatin12$79$7

Year by year

Part D prescribing by year
20248740NoneNone$3,234
202359612015% (87)None$20,782
202297930210% (96)11%$29,013
20215718811% (62)None$11,827
20202228128% (61)None$4,930
201934917244% (152)None$20,116
201835618336% (128)10%$11,415
201737321030% (111)None$17,629
20162267110% (23)12%$5,997
20157434NoneNone$2,095

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 12 drugs

Part D drugs prescribed in 2023
Eliquis11$8,021$729
Clopidogrel92$1,017$11
Atorvastatin95$995$10
Hydrocodone-Acetaminophen74$546$7
Potassium Chloride37$500$14
Carvedilol45$393$9
Metoprolol50$305$6
Lisinopril13$221$17
Amiodarone13$212$16
Furosemide45$180$4
Cephalexin16$173$11
Amlodipine Besylate20$82$4

2022: 19 drugs

Part D drugs prescribed in 2022
Atorvastatin111$1,160$10
Clopidogrel101$933$9
Hydrocodone-Acetaminophen89$551$6
Potassium Chloride45$530$12
Cephalexin50$392$8
Carvedilol44$338$8
Amoxicillin-Clavulanate Potass18$333$19
Gabapentin18$245$14
Amiodarone20$209$10
Metoprolol49$207$4
Diclofenac11$186$17
Furosemide52$182$4
Methylprednisolone21$172$8
Ciprofloxacin22$162$7
Fluticasone Propionate11$122$11
Lisinopril12$105$9
Ibuprofen13$91$7
Amlodipine Besylate16$89$6
Azithromycin20$78$4

2021: 10 drugs

Part D drugs prescribed in 2021
Atorvastatin93$774$8
Clopidogrel94$679$7
Amiodarone27$666$25
Potassium Chloride40$436$11
Hydrocodone-Acetaminophen61$291$5
Metoprolol58$284$5
Carvedilol28$182$7
Furosemide51$163$3
Cephalexin13$82$6
Lisinopril13$65$5

2020: 6 drugs

Part D drugs prescribed in 2020
Oxycodone30$246$8
Potassium Chloride14$155$11
Hydrocodone-Acetaminophen27$145$5
Clopidogrel15$98$7
Atorvastatin12$66$5
Furosemide11$21$2

2019: 7 drugs

Part D drugs prescribed in 2019
Oxycodone105$753$7
Gabapentin20$367$18
Amoxicillin-Clavulanate Potass26$361$14
Levothyroxine22$222$10
Hydrocodone-Acetaminophen36$216$6
Chlorhexidine Gluconate21$122$6
Ibuprofen11$42$4

2018: 6 drugs

Part D drugs prescribed in 2018
Oxycodone79$795$10
Gabapentin23$740$32
Levothyroxine26$373$14
Hydrocodone-Acetaminophen39$325$8
Chlorhexidine Gluconate26$136$5
Trazodone11$38$3

2017: 6 drugs

Part D drugs prescribed in 2017
Levothyroxine40$816$20
Gabapentin14$789$56
Hydrocodone-Acetaminophen55$706$13
Oxycodone43$517$12
Atorvastatin15$372$25
Famotidine12$185$15

2016: 5 drugs

Part D drugs prescribed in 2016
Levothyroxine105$1,574$15
Hydrocodone-Acetaminophen15$1,336$89
Calcitriol18$315$18
Omeprazole14$222$16
Liothyronine12$168$14

2015: 1 drug

Part D drugs prescribed in 2015
Levothyroxine27$433$16

Money from drug and device companies

$36 in 2024

Industry payments by year
202422None$36
202111None$21

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
PolyNovo North AmericaNovosorb Btm$19
1 payment
  • Meals for Novosorb Btm · 2024-11-05 · $19
StrykerEssx$17
1 payment
  • Meals for Essx · 2024-09-12 · $17
See all 2 published payments
Every published payment
PolyNovo North AmericaMeals · 2024-11-05Novosorb Btm$19
StrykerMeals · 2024-09-12Essx$17
See earlier years (2021)

2021: $21

Payments by company in 2021
Getinge USA SalesVasoview Hemopro 2$21
1 payment
  • Meals for Vasoview Hemopro 2 · 2021-04-13 · $21

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
79.2 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1336524099
Licence
CA 53399, NY 018880California C53399: Current · expires 2028-04-30
More record details
Sole proprietor
No
Taxonomy
Physician assistant (363A00000X)
Mailing address
300 Pasteur Drive, Stanford, CA, 94305
NPI first listed
2015-07-23
NPI last updated
2017-11-06

This is when the NPI record was last certified, not a medical board exam.